Nature Neuroscience
- 9, 1534 - 1540 (2006)
Published online: 19 November 2006; | doi:10.1038/nn1804
Dynorphin A activates bradykinin receptors to maintain neuropathic painJosephine Lai, Miaw-Chyi Luo, Qingmin Chen, Shouwu Ma, Luis R Gardell, Michael H Ossipov & Frank Porreca
Department of Pharmacology, University of Arizona Health Sciences Center, 1501 N. Campbell Ave., Tucson, Arizona 85724, USA.
Correspondence should be addressed to Josephine Lai lai@u.arizona.edu Dynorphin A is an endogenous opioid peptide that produces non-opioid receptor-mediated neural excitation. Here we demonstrate that dynorphin induces calcium influx via voltage-sensitive calcium channels in sensory neurons by activating bradykinin receptors. This action of dynorphin at bradykinin receptors is distinct from the primary signaling pathway activated by bradykinin and underlies the hyperalgesia produced by pharmacological administration of dynorphin by the spinal route in rats and mice. Blockade of spinal B1 or B2 receptor also reverses persistent neuropathic pain but only when there is sustained elevation of endogenous spinal dynorphin, which is required for maintenance of neuropathic pain. These data reveal a mechanism for endogenous dynorphin to promote pain through its agonist action at bradykinin receptors and suggest new avenues for therapeutic intervention.
MORE ARTICLES LIKE THIS These links to content published by NPG are automatically generated.
|
